Search

You searched for "presentation"

718 results found

In conversation with Ahmed Ali

12 May 2025 | URO - Core Urology
We were delighted to chat to Ahmed Ali about the journey to pursing a urological career in the UK and his decision to found the Arabic-British Urological Society. You grew up in Iraq and went to university in Baghdad; what...

Burnout in surgery

5 May 2021 | | URO - Core Urology
When I was pregnant with my first child, I went to a talk on how to achieve work-life balance and avoid burnout. It was given by a highly respected Australian surgeon and I was eager to hear the secrets that...

BAUS Section of Trainees (BSoT)

3 May 2022
7-9 March 2022 • Edinburgh, UK • Nicholas Boxall, Chair (Elect), BSoT, ST6 Urology, Health Education East of England; and Neil Harvey, BSoT Chair, ST7 Urological Surgery, North West Deanery. The BSoT conference kicked off on Monday 7 March with...

Penile augmentation using injectable filler

11 July 2023 | | URO - Andrology
Penile size is a major topic for many men and a source of anxiety throughout history. The common belief that a large penis is necessary to impress and satisfy their sexual partners has led to the notion that ‘bigger is...

Priapism in sickle cell disease

2 March 2022 | | URO - Andrology
What is sickle cell disease? Sickle cell disease (SCD) is one of the most common single-gene disorders in the UK affecting approximately one in every 2000 live births. Approximately 20-25 million people worldwide have SCD. It predominately affects those of...

Prolapse surgery with mesh: where do we stand in 2017? An ICS update

1 November 2017 | | URO - Functional / Reconstructive Urology
Background Surgery for pelvic organ prolapse (POP) is common among women. The lifetime risk of undergoing at least one surgical procedure for POP is up to 20% [1]. This kind of surgery will be increasingly important due to an ageing...

Mechanisms and prevention of catheterisation associated urethral injury (CAUI)

5 November 2019 | | URO - Neurourology, URO - Infection, URO - Functional / Reconstructive Urology, URO - Technology
Urethral catheterisation is a common procedure performed by health professionals across different grades and specialties in a variety of clinical settings. An estimated 15-25% of hospitalised patients have a urinary catheter inserted during their inpatient stay and up to 13%...

Discovering urology during the foundation programme

6 November 2024 | | URO - Core Urology
My journey to finding urology as a chosen career was not linear. During medical school, I always enjoyed studying urological and renal pathologies. I was exposed to one week of urology placement during my fourth year ‘surgical block’, where I...

Meeting in the middle: a review of the rendezvous technique to treat impassable ureteric strictures and transected ureters

1 August 2015 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology
Introduction Complex ureteric strictures present a significant challenge with some patients undergoing multiple separate urological and radiological procedures to try to cross a stricture without success. Cross-departmental collaboration with uroradiology may allow a decrease in the number of separate interventions....

Fournier’s gangrene

1 May 2015 | | URO - Infection
Introduction Fournier’s gangrene (FG) is a rare but fulminant form of infective necrotising fasciitis affecting the perineum and external genitalia, which can rapidly progress along fascial planes. It most commonly affects men, but can occur in women and children, with...

Movember launches world’s largest cancer real world evidence network

6 December 2021 | URO - Urologic Oncology
Movember has launched the world’s largest prostate cancer and testicular clinical and research network, aimed at improving the overall survival and quality of life for those living with diseases that affect over 1.4 million men worldwide every year. The leading...

Neuroendocrine bladder tumour

5 February 2025 | | URO - Urologic Oncology
A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...